Health Encyclopedia

VIPoma

Definition

VIPoma is a very rare type of cancer that usually grows from certain cells in the pancreas.

Alternative Names

Vasoactive intestinal peptide-producing tumor; Pancreatic endocrine tumor

Causes, incidence, and risk factors

VIPoma causes cells in the pancreas to produce high levels of a hormone called vasoactive intestinal peptide (VIP). This hormone increases secretions from the intestines and relaxes some of the smooth muscles in the GI system.

The cause is not known.

VIPomas are usually diagnosed in adults, most commonly at age 50. Women are more likely to be affected than men. This cancer is rare, affecting an estimated 1 in 10 million people per year.

Symptoms

Abdominal pain and cramping
Flushing or redness of the face
Nausea
Watery diarrhea (often massive amounts)
Weight loss

Signs and tests

Signs may include:

Dehydration
High volume of diarrhea (even without eating)
Low stomach acid (achlorhydria)
Low blood potassium (hypokalemia), which can cause leg cramps

Tests include:

CT scan
MRI
Stool examination for cause of diarrhea and electrolyte levels
Vasoactive intestinal peptide (VIP) in the blood

Treatment

The first goal of treatment is to correct dehydration. Fluids are often given through a vein (intravenous fluids) to replace fluids lost in diarrhea.

The next goal is to slow the diarrhea. Some medications can help control diarrhea. Ocreotide, which is a man-made form of a natural hormone, blocks the action of VIP.

The best chance for a cure is surgery to remove the tumor. If the tumor has not spread to other organs, surgery can often cure it.

Expectations (prognosis)

Surgery can usually cure VIPomas. However, in one-third to one-half of patients, the tumors have spread by the time of diagnosis and are not curable.

Complications

Cancer spread (metastasis)
Cardiac arrest from electrolyte imbalances
Dehydration

Calling your health care provider

If you have watery diarrhea for more than 2-3 days, call your doctor.

References

Jensen RT, Norton JA. Endocrine tumors of the pancreas and gastrointestinal tract. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 8th ed. Philadelphia, Pa: Saunders Elsevier; 2006:chap 31.

Review Date:9/4/2008
Reviewed By:Sean O. Stitham, MD, private practice in Internal Medicine, Seattle, Washington; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.